fludarabine has been researched along with Hepatitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balère-Appert, ML; Boiron, JM; Bordigoni, P; Chir, Z; Galambrun, C; Kanold, J; Maillard, N; Marie-Cardine, A; Maury, S; Milpied, N; Socié, G; Yakouben, K | 1 |
1 other study(ies) available for fludarabine and Hepatitis
| Article | Year |
|---|---|
Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient.
Topics: Adolescent; Adult; Anemia, Aplastic; Antilymphocyte Serum; Cause of Death; Chi-Square Distribution; Child; Child, Preschool; Cohort Studies; Combined Modality Therapy; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hemoglobinuria, Paroxysmal; Hepatitis; Histocompatibility Testing; HLA Antigens; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Kaplan-Meier Estimate; Living Donors; Lymphocyte Depletion; Male; Middle Aged; Proportional Hazards Models; Reoperation; Retrospective Studies; Statistics, Nonparametric; Survival Analysis; Survival Rate; T-Lymphocytes; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2007 |